Tekla Life Sciences Investors (HQL)

US · Financial Services · Asset Management

$18.09+4.21%

Last close · 2026-11-06

Latest quarter · ended 2026-03-31

Revenue

$48.1M

Revenue YoY

+2227.6%

Net profit

$65.3M

Profit YoY

+30.0%

Net margin

135.9%

Key statistics

Market cap

$538.2M

P/E

2.8

Forward P/E

0.0

P/B

0.98

Book value

$18.44

EPS (TTM)

$6.64

Dividend yield

10.54%

52-week high

$22.04

52-week low

$13.85

50-day MA

$18.95

200-day MA

$18.26

Beta

0.73

Shareholding

Insiders

0.00%

Institutions

38.37%

Corporate actions

Action	Detail	Date
Dividend	$0.62 / share ex-date Aug 24, 2026 · pay Sep 30, 2026	2026-08-24
Dividend	$0.56 / share ex-date May 21, 2026 · pay Jun 30, 2026	2026-05-21
Dividend	$0.56 / share ex-date Feb 20, 2026 · pay Mar 31, 2026	2026-02-20
Dividend	$0.50 / share ex-date Nov 21, 2025 · pay Jan 12, 2026	2025-11-21

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tekla Life Sciences Investors — free to start.

Open in the app Google Play App Store

Other Financial Services companies

Berkshire Hathaway Inc Berkshire Hathaway Inc JPMorgan Chase & Co Visa Inc. Class A Mastercard Inc Bank of America Corp HSBC Holdings PLC ADR Morgan Stanley Royal Bank of Canada Wells Fargo & Company Goldman Sachs Group Inc Mitsubishi UFJ Financial Group Inc ADR

Data updated 2026-11-07.